| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $388.8M | +49.7% |
| Cost of Revenue | $205.2M | +41.6% |
| Gross Profit | $183.6M | +59.9% |
| R&D Expense | $62.2M | +81.9% |
| SG&A Expense | $22.5M | +47.7% |
| Operating Income | $59.0M | +52.5% |
| Interest Expense | $1.7M | +116.3% |
| Pre-tax Income | $67.4M | +56.5% |
| Income Tax | $16.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $248.0M | -56.0% |
| Short-term Investments | $20.2M | -31.5% |
| Accounts Receivable | $182.9M | +73.3% |
| Inventory | $393.2M | +80.3% |
| Current Assets | $963.8M | +1.1% |
| Total Assets | $1.24B | +17.4% |
| Current Liabilities | $396.2M | +92.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$62.2M | -55.1% |
| Capital Expenditures | $91.1M | +895.2% |
| Investing Cash Flow | -$265.7M | -2255.2% |
| Financing Cash Flow | $45.9M | -91.5% |
| Free Cash Flow | -$153.3M | -211.3% |
| — |
| Net Income | $39.3M | +4.0% |
| EPS (Basic) | $0.66 | -66.3% |
| EPS (Diluted) | $0.59 | -65.9% |
| Long-term Debt |
| $21.0M |
| -17.2% |
| Total Liabilities | $423.3M | +76.0% |
| Stockholders' Equity | $674.9M | -0.2% |